Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Ensysce Biosciences, Inc. (ENSC) had Non-Operating Income/Expense of $0.01M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.49M |
|
$-3.73M |
|
-- |
|
$0.49M |
|
$4.23M |
|
$-3.74M |
|
|
Non-Operating Income/Expense |
$0.01M |
$-3.73M |
|
$-3.73M |
|
$-3.73M |
|
$-3.73M |
|
$-3.73M |
|
$-3.73M |
|
$-3.74M |
|
$-3.74M |
|
2.89M |
|
2.89M |
|
$-1.29 |
|
$-1.29 |
|
| Balance Sheet Financials | |
$2.93M |
|
$0.12M |
|
$0.25M |
|
$3.18M |
|
$2.30M |
|
-- |
|
$0.00M |
|
$2.30M |
|
$0.87M |
|
$0.87M |
|
$0.87M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-6.28M |
|
$-0.12M |
|
$4.58M |
|
$3.50M |
|
$1.67M |
|
$-1.83M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
100.00% |
|
-758.68% |
|
-758.68% |
|
-- |
|
-756.26% |
|
-756.26% |
|
$-6.28M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
111.79 |
|
0.81 |
|
-426.32% |
|
-426.33% |
|
-117.29% |
|
-426.33% |
|
$0.28 |
|
$-2.18 |
|
$-2.18 |
|